Modern Anti Tumour therapies in Urological Tumours

Abstract

My thesis talks about urological cancers in detail , explaining the pathophysiology of each one . It emphasizes the traditional and modern anti tumours therapies . Modern anti-tumor therapy in urological cancers is characterized by mechanism-driven approaches: Targeted agents (TKIs, FGFRi, PARPi) Immune checkpoint inhibitors Antibody-drug conjugates Radioligand therapies The shift to personalized oncology—guided by molecular profiling, biomarker-driven trials, and precision medicine—has drastically improved outcomes in kidney, ureter, bladder, urethra, and prostate cancers. Future goals include: Improved access to molecular diagnostics Intelligent therapy sequencing Combating resistance through rational combinations